Kannoli Pharma

Kannoli Pharma (“Kannoli”), a brand owned by Alkannoli L.D.A, is a new ’disruptor‘ in the nascent but fast growing European Medical Cannabis industry, with an overaching strategy to grow, extract and manufacture EU-GMP certified medical cannabis products, initially for the EU market. Kannoli’s expandable production facility will be a stand out environmental project, addressing the need for the production of consistent, high quality, and innovative cannabis products for the EU healthcare market. Medical Cannabis extracts and applications are used in the treatment of a wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, etc.